Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion-related macular oedema: A prospective randomized comparison-Comment

Clin Exp Ophthalmol. 2019 Jul;47(5):686-687. doi: 10.1111/ceo.13483. Epub 2019 Apr 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors
  • Bevacizumab
  • Dexamethasone
  • Humans
  • Intravitreal Injections
  • Macular Edema*
  • Prospective Studies
  • Retinal Vein Occlusion*

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab
  • Dexamethasone